Clinical Trial

Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This study explores the use of a minimally invasive screening tool (a sponge on a string device) to detect Barrett's esophagus and esophageal adenocarcinoma and to develop a laboratory test for the detection of Barrett's esophagus-high grade dysplasia and esophageal adenocarcinoma.
Protocol Amendment History 3 changes
notable Enrollment increased: 300 -> 450 participants 2026-05-07
notable Primary completion pushed: 2028-10-31 -> 2030-07-31 2026-04-18
minor Completion pushed: 2028-10-31 -> 2030-07-31 2026-04-18
Trial Details
NCT Number NCT07212491
Lead Sponsor Mayo Clinic
Collaborators: National Cancer Institute (NCI)
Conditions Barrett Esophagus, Esophageal Adenocarcinoma
Enrollment 450 participants
Start Date 2025-11-17
Primary Completion 2030-07-31 (estimated)
Study Completion 2030-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-06